Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.47

+0.3%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4132)	6/15/2001 5:17:23 PM
From: Biomaven	Read Replies (3) of 52153

And for some "homework" over the weekend, I would strongly encourage people to listen to the HGSI analyst day presentation. I was extremely impressed, and I learnt a lot. Incidentally, they have re-iterated their 100k (or more) human gene claim on an "apples to apples" basis (not counting alternative splicings as multiple genes). Haseltine noted with some amusement that the Genome Project count had already increased (now standing at about 37k). I don't really think it matters that much from an investment viewpoint, but it's still a fun controversy. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next